These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1578663)

  • 1. [Blood purification in chronic renal failure with severe liver disease].
    Sudo M
    Nihon Rinsho; 1992 Jan; 50 Suppl():112-7. PubMed ID: 1578663
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure.
    De Vecchi AF; Colucci P; Salerno F; Scalamogna A; Ponticelli C
    Am J Kidney Dis; 2002 Jul; 40(1):161-8. PubMed ID: 12087574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis in the treatment of renal failure in patients with liver disease.
    Wilkinson SP; Weston MJ; Parsons V; Williams R
    Clin Nephrol; 1977 Jul; 8(1):287-92. PubMed ID: 884909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid in end-stage renal disease treated by hemodialysis.
    Orasan OH; Orasan RA; Patiu IM; Dumitrascu DL
    Ren Fail; 2015; 37(9):1531-2. PubMed ID: 26337537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral health in patients with chronic renal failure].
    Bots CP; Brand HS; Franse RL; van Nieuw AA
    Ned Tijdschr Tandheelkd; 2006 May; 113(5):182-5. PubMed ID: 16729562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Water-electrolyte and acid-base disorders in terminal chronic renal insufficiency. Their treatment by peritoneal dialysis].
    Exposito C; Baumelou A
    Soins; 1981 Feb; 26(3):37-42. PubMed ID: 6910230
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological impairment in chronic kidney failure with long-term dialysis].
    Ota Z; Amano T
    Nihon Rinsho; 1992 Jan; 50 Suppl():637-42. PubMed ID: 1578747
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis in the ESRD setting: defining the risks.
    Dickenson L
    Nephrol News Issues; 1998 May; 12(5):13-5, 50. PubMed ID: 9644451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional monitoring techniques in dialysis. Can routine monitoring impact outcome?
    Zabetakis PM
    ASAIO J; 1997; 43(3):243-5. PubMed ID: 9152502
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac arrhythmia in chronic renal failure: Holter monitoring during hemodialysis and intermittent peritoneal dialysis.
    Grushka E; Garty J; Kristal B; Goldhammer E; Abineder EG; Shasha SM
    Isr J Med Sci; 1990 Jul; 26(7):378-82. PubMed ID: 2387709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis in patients with cirrhosis and ascites.
    Guest S
    Adv Perit Dial; 2010; 26():82-7. PubMed ID: 21348386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis G virus infection in hemodialysis patients from urban Delhi.
    Kumar D; Arora A; Singh NP; Kohli R; Kar P; Das BC
    Ren Fail; 2005; 27(1):87-93. PubMed ID: 15717640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients on dialysis as renal graft recipients].
    Grenda R
    Pol Merkur Lekarski; 2001 Apr; 10(58):300-2. PubMed ID: 11434186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of protein and lipid metabolism associated with chronic renal failure and chronic dialysis.
    Krumlovsky FA
    Ann Clin Lab Sci; 1981; 11(4):350-60. PubMed ID: 7023349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring the course of non-A, non-B viral hepatitis in patients with chronic renal insufficiency].
    Chalupa P; Kolácný I; Horák Z; Jezek P
    Vnitr Lek; 1990 May; 36(5):473-8. PubMed ID: 2115703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management and diagnosis of water electrolyte imbalance due to kidney diseases].
    Takemoto F; Hara S
    Nihon Naika Gakkai Zasshi; 2003 May; 92(5):757-63. PubMed ID: 12808898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in joints during the hemo- and peritoneal dialysis].
    Pasić I; Popović V; Susić H
    Med Arh; 1974 Jan; 28(0):suppl:41-3. PubMed ID: 4839882
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What unique acid-base considerations exist in dialysis patients?
    Oh MS; Uribarri J; Weinstein J; Schreiber M; Kamel KS; Kraut JA; Madias NE; Laski ME
    Semin Dial; 2004; 17(5):351-64. PubMed ID: 15461741
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysis-related infections.
    Crespo J
    Heart Lung; 1982; 11(2):111-7. PubMed ID: 6800977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.